Metsera

About Metsera

Metsera is a clinical-stage biotechnology company focused on engineering and developing NuSH (nutrient-stimulated hormone) therapies for obesity and related diseases. The company pursues injectable and oral, ultra-long-acting therapies designed to be scalable and tolerable, with a strong emphasis on peptide engineering, translational science, and large-scale manufacturing. Metsera aims to deliver convenient and affordable obesity treatments and is operating within the biotech and pharmaceutical landscape; the site notes that Metsera was acquired by Pfizer, positioning the venture within Pfizer's portfolio. The content centers on obesity therapeutics and metabolic health, with global implications for weight management and related conditions.